That is very important, because the method a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. In other words, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (last week). Now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. This was an advancement practically no one observed. But it's going to have profound ramifications for curing illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown investment prediction). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I would not be surprised if it pulled back perhaps significantly before going higher - melania trump. I have actually been covering bitcoin for a long period of time now. Among the very first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. However that's not the huge concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown investment prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of fantastic personal business on the brink of striking the public markets And I have actually been dealing with a brand-new way for you to invest even before these companies go public.
This opportunity has been constructing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the details. Go right here to book your spot for totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers know that tech isn't our usual beat (first lady). And when it pertains to tech investing, we leave it to the professionals. The good news is, we have a number of such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our long time readers. He is among the most accomplished tech investing experts we understand (future report). In reality, he had a number of triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take an appearance at the huge photo and forecast what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing rapid development and developing amazing chances for investors. I want to make sure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a subject I've been covering for years now. jeff brown stock market prediction. But regardless of what many readers may think, this is a pattern that's just getting going. Even though the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually resulted in Apple delaying the release of the 5G-enabled i, Phone 12 by two months (legacy report prediction). Losing two months of production and sales really impacts how lots of 5G devices are sold in the calendar year. When you consider all of that, selling 250 million units is impressive. More significantly, the hold-ups brought on by the pandemic produced a load of suppressed need. Which need is now going to be pushed into 2021. In fact, I anticipate that more than 500 million 5G devices will be delivered in 2021 - jeff brown top biotech stock 2021. Which's not my only 5G prediction When I've talked about 5G in the past, I have actually described its 3 different stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services start to be offered (self-driving cars). That's when we begin to see applications operating on 5G networks. Consider things like massive multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Phase Three by this summertime. This starts something of a virtuous cycle: Many individuals don't truly care about the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open a suite of unbelievable applications: self-driving cars and trucks, the Internet of Things, robotic surgery, and more. All of these technologies need 5G. The investment opportunities moving forward will be massive. Stepping far from 5G, the next important technology I predict in 2021 is CRISPR hereditary editing. CRISPR means "clustered regularly interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software.
The program can crash or not work properly. CRISPR utilizes a similar concept but with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For many years, CRISPR was mostly a niche technology that wasn't well comprehended. And during that time, there were actually just 3 business running in this space. However things are changing. CRISPR is no longer just theoretical. We're seeing real results. We're treating diseases and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire industry is successfully a greenfield opportunity.
There's space for lots of business to exist in this area. last week. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or three more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing remarkable things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its most current Alpha, Fold software application can properly forecast the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is essential due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and be effective.
Historically, this has been a trial-and-error process. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to create drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug treatments produced utilizing this technology. This was among those advancements that almost nobody observed. However it's going to have profound ramifications for treating disease. And, naturally, there will be a lot of investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it pulled back possibly significantly before going greater. I've been covering bitcoin for a long period of time now. One of the very first research reports I ever published was on bitcoin - jeff brown biotech stock. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anyone who followed my recommendation. However at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that question any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. the legacy report prediction. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information is up to date as of February 2021, however we might not separately verify this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down a precise figure at this moment. Brown is best understood for his sage-like ability to pick winning technology stocks. He spent more than 25 years looking into innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience gives him an outstanding perspective on the marketplace. He's constantly on the hunt for new chances, and he shares much of his finest picks in the Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an exceptional track record as a stock-picker, and he successfully forecasted some of the most significant financial occasions of the past 20 years. Although he does not appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it ideal every time, however Jeff Brown's precise predictions have actually made him legions of dedicated followers. That states a lot about his capability. The Future Report is released by Brownstone Research, a popular financial research study publisher. Brownstone Research uses numerous research services with a broad range of specializations - longtime readers.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - white house. On its site, Brownstone states its mission is to provide retail investors with professional-grade research study: "For too long, the very best investment research study has not been available to specific financiers. It has been generally scheduled for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown predictions for 2021. The objective of Brownstone Research is to make that type of exclusive research study available to any financiers wanting to get an edge in the marketplaces. The goal is basic to provide distinct and profitable financial investment research study discovered no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also acts as the company's Chief Financial investment Analyst.
With Brown directing the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After years of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you know even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. black sea. Everything he touches turns to gold! Jeff is well mindful of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown thinks S.A.V. jeff brown investor prediction. could be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 advanced technologies: artificial intelligence and electrical vehicles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving cars and trucks ever. It's nothing except the vehicle market's Holy Grail. As you understand, electrical automobiles and self-driving vehicle stocks have been huge this year, but the Wall Street machine has actually approved buzz without much concrete result. Regardless of a drastic boost in competition over the previous couple of years, Brown still thinks Musk has the finest possibility of putting all of it together.
tech might be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Automobile, and it could be the future of transportation. Essentially, this technology would permit you to lease your cars and truck as an autonomous, self-driving taxi when you're not using it. You simply get out of the car and press a button on an app that tells the cars and truck to "join the fleet." Next thing you know, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a large piece of the earnings. It sounds ridiculous, but it might be closed than you believe.